ICHR reported strong Q3 FY2025 net sales of \(239.3 million (up 13.3% YoY), driven largely by the Singapore segment. However, GAAP profitability severely deteriorated, with the 9-month net loss widening to \)(36.8M)\( from \)(16.9M)\( previously, pushing diluted EPS to \)(1.08)$.
This performance pressure is directly attributed to a Consolidation Restructuring Plan approved in Q3, which immediately triggered a $16.7 million inventory impairment charge recognized in Cost of Sales, causing the GAAP gross margin to collapse to 4.6%. Additional restructuring charges of $1.7 million (including l
...